| Synonyms: | |
| Status: | Approved (1952) |
| Entry Type: | Small molecule |
| Molecule Category: | Parent |
| ATC: | C04AB01 |
| UNII: | Z468598HBV |
| InChI Key | MRBDMNSDAVCSSF-UHFFFAOYSA-N |
|---|---|
| Smile | |
| InChI |
|
| Property Name | Value |
|---|---|
| Molecular Formula | C17H19N3O |
| Molecular Weight | 281.36 |
| AlogP | 2.84 |
| Hydrogen Bond Acceptor | 4.0 |
| Hydrogen Bond Donor | 2.0 |
| Number of Rotational Bond | 4.0 |
| Polar Surface Area | 47.86 |
| Molecular species | BASE |
| Aromatic Rings | 2.0 |
| Heavy Atoms | 21.0 |
| Primary Target | |
|---|---|
| α1A-adrenoceptor | |
| α1B-adrenoceptor | |
| α1D-adrenoceptor |
| Targets | EC50(nM) | IC50(nM) | Kd(nM) | Ki(nM) | Inhibition(%) | |
|---|---|---|---|---|---|---|
|
Ion channel
Voltage-gated ion channel
Voltage-gated sodium channel
|
- | 8400 | - | - | 55 | |
|
Membrane receptor
Family A G protein-coupled receptor
Small molecule receptor (family A GPCR)
Monoamine receptor
Adrenergic receptor
|
- | 3-39 | 4-138 | 10-90 | - | |
|
Membrane receptor
Family A G protein-coupled receptor
Small molecule receptor (family A GPCR)
Monoamine receptor
Histamine receptor
|
- | 12589 | - | - | - | |
|
Membrane receptor
|
- | 3-39 | 4-138 | 10-90 | - | |
|
Other cytosolic protein
|
- | - | - | 11-11 | - |
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Mydriasis | 3 | D015878 | ClinicalTrials |
| Presbyopia | 2 | D011305 | ClinicalTrials |
| Hypoglycemia | 0 | D007003 | ClinicalTrials |
| Obesity | 0 | D009765 | ClinicalTrials |
| Resources | Reference |
|---|---|
| CAS NUMBER | 50-60-2 |
| ChEBI | 8081 |
| ChEMBL | CHEMBL597 |
| DrugBank | DB00692 |
| DrugCentral | 2142 |
| EPA CompTox | DTXSID4023462 |
| FDA SRS | Z468598HBV |
| Human Metabolome Database | HMDB0014830 |
| Guide to Pharmacology | 502 |
| PharmGKB | PA450926 |
| PubChem | 5775 |
| SureChEMBL | SCHEMBL5653 |
| ZINC | ZINC000000020251 |